| Literature DB >> 35474116 |
Katherine Froehlich-Grobe1,2,3, Jaehoon Lee4, Christa Ochoa5,6, Amber Lopez5,7, Erina Sarker5,6, Simon Driver5,6, Ross Shegog8, Suh-Jen Lin9.
Abstract
STUDYEntities:
Mesh:
Substances:
Year: 2022 PMID: 35474116 PMCID: PMC9041282 DOI: 10.1038/s41393-022-00787-w
Source DB: PubMed Journal: Spinal Cord ISSN: 1362-4393 Impact factor: 2.473
Fig. 1Consort Diagram.
Fig. 2Participation in virtual sessions and exercise from individuals who initiated (n = 143) the 16-week WOWii program.
The x-axis reflects the program weeks and months and the y-axis relfects the proportion of participants.
Fig. 3WOWii participants participation in the program (n = 143).
The x-axis reflects data for regarding program participation related to attending virtual sessions and exercise, while the y-axis indicates the proportion of participants. Color gradations indicate the number of months the proportion participants were involved.
Fig. 4Exercise data based on Polar recording (n = 123).
The x-axis indicates each of the 24 study weeks, below which the sample size are derived for data regarding aerobic and strength training. The y-axis along the left side of the figure reflects the number of weekly minutes and along the right side the number of days individuals participated in aerobic and strength training.
Combined groups physiologic outcomes over the 16-week WOWii trial by SCI level, DFW enrolled participants.
| Physiologic Outcomes | Paraplegia ( | Tetraplegia ( | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 4 months | 0–4 months change | Baseline | 4 months | 0–4 months change | Effect | Group* | |||||||||||||
| size ( | Time | |||||||||||||||||||
| V̇O2 peak | 36 | 11.46 | 2.94 | 24 | 12.13 | 2.69 | 23 | 0.52 | 1.44 | 15 | 10.26 | 4.43 | 11 | 11.04 | 5.15 | 10 | 0.52 | 1.91 | 0.001 | 0.795 |
| Watts max | 37 | 47.43 | 16.19 | 24 | 49.79 | 18.50 | 24 | 2.92 | 6.90 | 15 | 23.13 | 18.88 | 11 | 25.00 | 19.24 | 10 | 1.00 | 5.16 | 0.297 | 0.452 |
| HR rest | 37 | 73.70 | 12.73 | 24 | 75.42 | 11.81 | 24 | 2.46 | 12.19 | 17 | 72.47 | 18.52 | 10 | 67.70 | 12.53 | 9 | −7.00 | 18.73 | 0.668 | 0.112 |
| HR max | 37 | 133.20 | 23.14 | 24 | 136.40 | 15.90 | 24 | 3.71 | 13.49 | 15 | 115.70 | 25.07 | 11 | 118.30 | 18.62 | 10 | 4.30 | 15.17 | −0.042 | 0.992 |
| HR reserve | 37 | 59.54 | 22.70 | 24 | 61.00 | 17.31 | 24 | 1.25 | 13.63 | 15 | 42.27 | 19.78 | 10 | 51.80 | 20.42 | 9 | 13.44 | 12.86 | −0.908 | 0.044 |
| Systolic BP | 37 | 117.20 | 19.48 | 24 | 119.60 | 18.20 | 24 | 0.33 | 15.10 | 17 | 102.40 | 19.58 | 10 | 103.20 | 15.75 | 9 | −3.22 | 14.76 | 0.237 | 0.665 |
| Diastolic BP | 37 | 75.43 | 12.61 | 24 | 75.83 | 11.84 | 24 | −0.75 | 7.69 | 17 | 69.24 | 10.81 | 11 | 62.73 | 7.21 | 10 | −7.90 | 12.71 | 0.763 | 0.052 |
| Weight (kg) | 37 | 89.89 | 20.53 | 24 | 89.78 | 22.77 | 24 | 0.93 | 3.18 | 17 | 74.96 | 20.85 | 11 | 71.17 | 17.41 | 10 | −1.15 | 2.87 | 0.672 | 0.109 |
| BMI | 37 | 29.77 | 5.66 | 24 | 30.06 | 6.45 | 24 | −0.02 | 1.45 | 16 | 23.89 | 6.04 | 11 | 22.91 | 5.78 | 10 | −0.33 | 0.96 | 0.231 | 0.631 |
Efficacy = the denominator was based on all enrollees (n = 168).
Effectiveness = the denominator reflects those who remained in the program (n = 133).
Fig. 5The x-axis reflects the program weeks and the y-axis the proportion of participants.
Weekly averages of participant engagement for attending meetings & completing online activities (n = 166).
WOWii participant demographic data.
| Variable | All ( | Intervention ( | Control ( | Between | |||
|---|---|---|---|---|---|---|---|
| Age (yr) | 168 | 49.6 | 87 | 48.6 | 81 | 50.6 | |
| 12.3 | 11.5 | 13.1 | 0.305 | ||||
| Time with disability (yr) | 168 | 15.5 | 87 | 14.8 | 81 | 16.2 | |
| 12.3 | 12.2 | 12.4 | 0.449 | ||||
| % | % | % | |||||
| Gender | 0.688 | ||||||
| Male | 96 | 57% | 51 | 59% | 45 | 56% | |
| Female | 72 | 43% | 36 | 41% | 36 | 44% | |
| Race | 0.181 | ||||||
| Black | 21 | 13% | 13 | 15% | 8 | 10% | |
| White | 131 | 78% | 63 | 72% | 68 | 84% | |
| Other | 16 | 10% | 11 | 13% | 5 | 6% | |
| Ethnicity | 0.789 | ||||||
| Non-Hispanic | 145 | 87% | 76 | 88% | 69 | 85% | |
| Hispanic | 14 | 8% | 6 | 7% | 8 | 10% | |
| Unknown | 8 | 5% | 4 | 5% | 4 | 5% | |
| Marital status | 0.77 | ||||||
| Married | 87 | 52% | 46 | 53% | 41 | 51% | |
| Not married | 81 | 48% | 41 | 47% | 40 | 49% | |
| Education level | |||||||
| High school or below | 13 | 8% | 11 | 13% | 2 | 2% | 0.077 |
| Tech/Some coll/Assoc Deg | 70 | 42% | 37 | 43% | 33 | 41% | |
| ≥Bachelor’s degree | 83 | 49% | 38 | 44% | 45 | 56% | |
| Other | 2 | 1% | 1 | 1% | 1 | 1% | |
| Employment status | 0.248 | ||||||
| Employed full/part-time | 60 | 36% | 35 | 40% | 25 | 31% | |
| Unemployed | 96 | 57% | 48 | 55% | 48 | 59% | |
| Other | 12 | 7% | 4 | 5% | 8 | 10% | |
| Income level | 0.378 | ||||||
| $0–39,000 | 63 | 38% | 37 | 43% | 26 | 32% | |
| $40,000–69,999 | 39 | 23% | 16 | 18% | 23 | 28% | |
| $70,000–99,999 | 32 | 19% | 17 | 20% | 15 | 19% | |
| >$100,000 | 34 | 20% | 17 | 20% | 17 | 21% | |
| Paraplegic or Tetraplegic | 0.598 | ||||||
| Paraplegic | 100 | 60% | 55 | 63% | 45 | 56% | |
| Tetraplegic | 66 | 39% | 31 | 36% | 35 | 43% | |
| Don’t know | 2 | 1% | 1 | 1% | 1 | 1% | |
| Wheelchair type | 0.824 | ||||||
| Manual wheelchair | 104 | 62% | 52 | 60% | 52 | 60% | |
| Power wheelchair | 60 | 36% | 33 | 38% | 27 | 31% | |
| Scooter | 4 | 2% | 2 | 2% | 2 | 2% | |
| Diabetes | 0.619 | ||||||
| Yes | 7 | 13% | 5 | 15% | 2 | 10% | |
| No | 47 | 87% | 29 | 85% | 18 | 90% | |
RCT physiologic data (DFW subsample n = 56) and self-report data (full sample N = 168).
| Self-report outcomes | Intervention ( | Wait-list Control ( | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 4 mos | 0–4 mos change | Baseline | 4 mos | 0–4 mos change | Effect | Group* | |||||||||||||||
| size ( | Time | |||||||||||||||||||||
| Primary outcomes | Physical Activity | |||||||||||||||||||||
| MPA (mins/wk) | 84 | 160 | 270 | 57 | 261 | 275 | 57 | 97 | 370 | 77 | 116 | 170 | 70 | 177 | 235 | 68 | 68 | 217 | 0.1 | 0.48 | 0.480 | |
| VPA (mins/wk) | 84 | 95 | 183 | 57 | 206 | 263 | 57 | 99 | 251 | 77 | 103 | 147 | 70 | 98 | 169 | 68 | 8 | 188 | 0.42 | 0.001* | 0.001 | |
| Walk/wheel time (mins/wk) | 84 | 210 | 352 | 57 | 270 | 360 | 57 | 28 | 460 | 77 | 248 | 396 | 70 | 189 | 319 | 68 | −26 | 371 | 0.13 | 0.201 | 0.229 | |
| Secondary outccomes | BHADP Total | 85 | 30.1 | 7.0 | 60 | 28.8 | 6.4 | 60 | −1.5 | 6.9 | 80 | 28.5 | 6.3 | 73 | 28.2 | 5.6 | 73 | −0.3 | 4.8 | −0.21 | 0.284 | 0.268 |
| BHADP Motivation | 85 | 12.7 | 3.4 | 60 | 12 | 3.1 | 60 | −1 | 3.5 | 80 | 12.3 | 3.0 | 73 | 12.3 | 2.9 | 73 | 0 | 2.9 | −0.31 | 0.092 | 0.088 | |
| BHADP External Barriers | 85 | 17.4 | 4.5 | 60 | 16.9 | 4.0 | 60 | −0.5 | 4 | 80 | 16.2 | 4.0 | 73 | 15.8 | 3.4 | 73 | −0.3 | 2.8 | −0.07 | 0.773 | 0.749 | |
| SRAHP Total | 85 | 80.2 | 18.2 | 60 | 84.1 | 14.9 | 60 | 3.1 | 13.8 | 80 | 84.7 | 15.1 | 73 | 86.3 | 15.1 | 73 | 1.8 | 11.6 | 0.1 | 0.471 | 0.437 | |
| SRAHP Exercise | 85 | 18.1 | 6.0 | 60 | 20 | 3.7 | 60 | 1.5 | 4.8 | 80 | 19.1 | 5.4 | 73 | 19.5 | 5.3 | 73 | 0.5 | 4.9 | 0.21 | 0.204 | 0.191 | |
| SRAHP Nutrition | 85 | 19.8 | 5.8 | 60 | 21 | 4.5 | 60 | 1 | 4.4 | 80 | 21.3 | 5.0 | 73 | 22.1 | 4.8 | 73 | 0.7 | 4.1 | 0.07 | 0.793 | 0.760 | |
| SRAHP Physical Well Being | 85 | 19.2 | 6.1 | 60 | 19.6 | 5.5 | 60 | 0.5 | 4.8 | 80 | 20.4 | 5.4 | 73 | 21 | 4.7 | 73 | 0.7 | 4.7 | −0.03 | 0.236 | 0.259 | |
| SRAHP Health Promotion | 85 | 23.2 | 4.2 | 60 | 23.5 | 4.1 | 60 | 0 | 3.6 | 80 | 23.9 | 3.2 | 73 | 23.8 | 3.4 | 73 | −0.1 | 2.9 | 0.04 | 0.857 | 0.845 | |
| SHS Total | 85 | 32.6 | 9.9 | 60 | 37 | 7.9 | 60 | 4.4 | 8.5 | 80 | 35.2 | 7.6 | 73 | 35.4 | 7.9 | 73 | 0 | 6.1 | 0.6 | 0.002* | 0.002 | |
| SHS Pathway | 85 | 17.9 | 4.8 | 60 | 19 | 4.1 | 60 | 0.9 | 3.8 | 80 | 18.9 | 3.5 | 73 | 18.7 | 4.0 | 73 | −0.4 | 3.2 | 0.35 | 0.100* | 0.090 | |
| SHS Agency | 85 | 14.7 | 6.0 | 60 | 18 | 4.3 | 60 | 3.5 | 5.6 | 80 | 16.3 | 4.9 | 73 | 16.7 | 4.7 | 73 | 0.3 | 3.8 | 0.67 | 0.000* | 0.000 | |
| Physiologic outcomes (DFW subsample) | Intervention ( | Wait-list control ( | ||||||||||||||||||||
| Baseline | 4 mos | 0–4 mos change | Baseline | 4 mos | 0–4 mos change | Effect | Group * | |||||||||||||||
| size ( | Time | Without covariates | ||||||||||||||||||||
| V̇O2 peak | 34 | 10.68 | 3.27 | 20 | 11.7 | 3.31 | 19 | 0.68 | 1.55 | 19 | 11.68 | 3.69 | 16 | 11.85 | 3.95 | 15 | 0.25 | 1.57 | 0.28 | 0.552 | 0.364 | |
| Watts max | 35 | 39.1 | 18.4 | 20 | 40.8 | 20.1 | 20 | 1.5 | 5.9 | 19 | 41.1 | 23.5 | 16 | 42.8 | 24.0 | 15 | 3.3 | 7 | −0.29 | 0.38 | 0.430 | |
| HR Rest | 36 | 74 | 16 | 19 | 77 | 11 | 19 | 3 | 14 | 20 | 73 | 10 | 16 | 70 | 13 | 15 | −4 | 14 | 0.55 | 0.071 | 0.175 | |
| HR Max | 35 | 124 | 26 | 20 | 132 | 19 | 20 | 7 | 11 | 19 | 132 | 25 | 16 | 128 | 18 | 15 | 0 | 16 | 0.46 | 0.098 | 0.117 | |
| HR Reserve | 35 | 50 | 24 | 19 | 57 | 16 | 19 | 4 | 12 | 19 | 58 | 25 | 16 | 58 | 22 | 15 | 5 | 17 | −0.02 | 0.911 | 0.793 | |
| Systolic BP | 36 | 114.1 | 19.6 | 20 | 115.5 | 18.0 | 20 | −2.4 | 14.5 | 20 | 109.2 | 21.5 | 15 | 114.4 | 20.1 | 14 | 3.7 | 16.4 | −0.4 | 0.374 | 0.303 | |
| Diastolic BP | 36 | 73.7 | 12.8 | 20 | 71.8 | 12.9 | 20 | −4.3 | 9.3 | 20 | 73.2 | 11.2 | 16 | 71.3 | 11.3 | 15 | −1 | 10.1 | −0.34 | 0.644 | 0.502 | |
| Weight (kg) | 36 | 86.2 | 22.0 | 20 | 85.2 | 23.8 | 20 | 0.5 | 3.5 | 20 | 81.6 | 20.8 | 16 | 81 | 21.8 | 15 | 0.2 | 2.8 | 0.09 | 0.563 | 0.797 | |
| BMI | 35 | 28.3 | 6.2 | 20 | 28.4 | 7.2 | 20 | 0.1 | 1.1 | 20 | 27.2 | 6.5 | 16 | 26.7 | 6.9 | 15 | −0.4 | 1.5 | 0.43 | 0.104 | 0.213 | |
PA moderate-intensity physical activity, VPA virgorous-intensity physical activity, BHADP Barriers to Health Adapated for People with Disability, SRAHP Self-Rated Abilities for Health Practices Scale, SHS State Hope Scale, BP blood pressure, kg kilograms, BMI body mass index. Analyses included the following covariates:???.
Combined immediate intervention (IMM) and WLC group self-reported outcomes after the 16-week trial and 2-month follow-up.
| Self-Report Outcomes | Baseline | 4 months | 6 months | Effect size ( | Time | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (full sample) | 0–6 mos | 0–4 mos | 4–6 mos | 0–6 mos | 0–4 mos | 4–6 mos | ||||||||||
| Primary Outcomes | Physical Activity | |||||||||||||||
| MPA (mins/wk) | 161 | 139.22 | 228.16 | 127 | 214.89 | 256.20 | 86 | 183.20 | 265.23 | 0.21 | 0.28 | −0.20 | 0.011* | 0.003* | 0.256 | |
| VPA (mins/wk) | 161 | 99.09 | 165.98 | 127 | 146.71 | 221.97 | 86 | 162.87 | 187.81 | 0.30 | 0.22 | −0.02 | 0.008* | 0.010* | 0.693 | |
| Walk/wheel time (mins/wk) | 161 | 228.04 | 373.11 | 127 | 225.10 | 339.03 | 86 | 268.42 | 373.07 | 0.04 | 0.00 | 0.00 | 0.777 | 0.886 | 0.496 | |
| Sit time (mins/day) | 115 | 616.22 | 229.19 | 95 | 567.05 | 264.86 | 68 | 555.13 | 252.28 | −0.41 | −0.19 | −0.25 | 0.017* | 0.076 | 0.233 | |
| Secondary Outccomes | BHADP Total | 165 | 29.33 | 6.70 | 133 | 28.46 | 5.97 | 89 | 27.11 | 5.81 | −0.35 | −0.15 | −0.34 | 0.000* | 0.059 | 0.014* |
| BHADP Motivation | 165 | 12.53 | 3.24 | 133 | 12.16 | 2.97 | 89 | 11.21 | 2.86 | −0.44 | −0.15 | −0.33 | 0.000* | 0.076 | 0.003* | |
| BHADP External Barriers | 165 | 16.80 | 4.31 | 133 | 16.30 | 3.73 | 89 | 15.90 | 3.79 | −0.23 | −0.11 | −0.22 | 0.019* | 0.129 | 0.144 | |
| SRAHP Total | 165 | 82.39 | 16.86 | 133 | 85.30 | 15.00 | 89 | 88.02 | 14.08 | 0.27 | 0.19 | 0.20 | 0.001* | 0.016* | 0.107 | |
| SRAHP Exercise | 165 | 18.59 | 5.72 | 133 | 19.71 | 4.67 | 89 | 20.73 | 4.06 | 0.32 | 0.20 | 0.28 | 0.000* | 0.012* | 0.036* | |
| SRAHP Nutrition | 165 | 20.50 | 5.43 | 133 | 21.59 | 4.69 | 89 | 22.16 | 4.44 | 0.29 | 0.20 | 0.17 | 0.001 | 0.008* | 0.187 | |
| SRAHP Physical Well Being | 165 | 19.76 | 5.75 | 133 | 20.36 | 5.10 | 89 | 20.92 | 5.42 | 0.16 | 0.13 | 0.04 | 0.075 | 0.090 | 0.546 | |
| SRAHP Health Promotion | 165 | 23.53 | 3.77 | 133 | 23.65 | 3.72 | 89 | 24.21 | 3.78 | 0.01 | −0.02 | 0.05 | 0.769 | 0.966 | 0.506 | |
| SHS Total | 165 | 33.86 | 8.90 | 133 | 36.08 | 7.93 | 89 | 37.98 | 7.42 | 0.52 | 0.26 | 0.21 | 0.000* | 0.001* | 0.012* | |
| SHS Pathway | 165 | 18.38 | 4.22 | 133 | 18.83 | 4.04 | 89 | 19.93 | 3.62 | 0.37 | 0.05 | 0.26 | 0.000* | 0.260 | 0.003* | |
| SHS Agency | 165 | 15.48 | 5.50 | 133 | 17.26 | 4.54 | 89 | 18.04 | 4.22 | 0.56 | 0.36 | 0.12 | 0.000* | 0.000* | 0.085 | |
| Physiological Outcomes | ||||||||||||||||
| (DFW subsample) | ||||||||||||||||
| VO2 peak | 53 | 11.04 | 3.43 | 36 | 11.77 | 3.55 | 0.32 | 0.018* | ||||||||
| Watts max | 54 | 39.8 | 20.1 | 36 | 41.7 | 21.6 | 0.36 | 0.038* | ||||||||
| HR Rest | 56 | 74 | 14 | 35 | 74 | 12 | 0.00 | 0.941 | ||||||||
| HR Max | 54 | 127 | 25 | 36 | 130 | 18 | 0.28 | 0.094 | ||||||||
| HR Reserve | 54 | 53 | 24 | 35 | 57 | 19 | 0.31 | 0.054 | ||||||||
| Systolic BP | 56 | 112.4 | 20.3 | 35 | 115.0 | 18.7 | 0.01 | 0.706 | ||||||||
| Diastolic BP | 56 | 73.5 | 12.1 | 36 | 71.6 | 12.0 | −0.30 | 0.125 | ||||||||
| Weight (kg) | 56 | 84.6 | 21.5 | 36 | 83.3 | 22.7 | 0.11 | 0.722 | ||||||||
| BMI | 55 | 27.9 | 6.3 | 36 | 27.6 | 7.0 | −0.08 | 0.475 | ||||||||
MPA moderate-intensity physical activity, VPA vigorous-intensity physical activity, BHADP barriers to health adapted for people with disability, SRAHP Self-Rated Abilities for Health Practices Scale, SHS State Hope Scale.